- Home
- NATL vs KNSA Comparison
NATL vs KNSA Comparison
Compare NATL & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATL
- KNSA
- Stock Information
- Founded
- NATL 2023
- KNSA 2015
- Country
- NATL United States
- KNSA United Kingdom
- Employees
- NATL N/A
- KNSA N/A
- Industry
- NATL
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- NATL
- KNSA Health Care
- Exchange
- NATL Nasdaq
- KNSA Nasdaq
- Market Cap
- NATL 2.9B
- KNSA 2.6B
- IPO Year
- NATL N/A
- KNSA 2018
- Fundamental
- Price
- NATL $38.47
- KNSA $40.36
- Analyst Decision
- NATL Buy
- KNSA Strong Buy
- Analyst Count
- NATL 4
- KNSA 7
- Target Price
- NATL $42.75
- KNSA $46.86
- AVG Volume (30 Days)
- NATL 354.1K
- KNSA 458.1K
- Earning Date
- NATL 11-11-2025
- KNSA 10-28-2025
- Dividend Yield
- NATL N/A
- KNSA N/A
- EPS Growth
- NATL N/A
- KNSA N/A
- EPS
- NATL 1.71
- KNSA 0.07
- Revenue
- NATL $4,271,000,000.00
- KNSA $529,332,000.00
- Revenue This Year
- NATL $2.73
- KNSA $53.93
- Revenue Next Year
- NATL $4.51
- KNSA $25.06
- P/E Ratio
- NATL $22.24
- KNSA $602.30
- Revenue Growth
- NATL N/A
- KNSA 56.18
- 52 Week Low
- NATL $22.30
- KNSA $17.82
- 52 Week High
- NATL $42.23
- KNSA $39.79
- Technical
- Relative Strength Index (RSI)
- NATL 51.45
- KNSA 68.19
- Support Level
- NATL $37.25
- KNSA $38.02
- Resistance Level
- NATL $39.07
- KNSA $39.45
- Average True Range (ATR)
- NATL 1.26
- KNSA 1.12
- MACD
- NATL -0.06
- KNSA -0.03
- Stochastic Oscillator
- NATL 48.07
- KNSA 98.31
About NATL NCR Atleos Corporation
NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.